Bal Pharma Limited has informed the Exchange regarding a press release dated May 24, 2021, titled "Launch of favipiravir formulation under the brand name BALflu , used in the treatment of COVID-19 virus.".
Bal Pharma Limited has informed the Exchange regarding a press release dated May 24, 2021, titled "Launch of favipiravir formulation under the brand name BALflu , used in the treatment of COVID-19 virus.".